Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Pediatr ; 243: 208-213.e3, 2022 04.
Article in English | MEDLINE | ID: mdl-34952008

ABSTRACT

In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.


Subject(s)
COVID-19 , Myocarditis , Adolescent , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , Myocarditis/epidemiology , Myocarditis/etiology , RNA, Messenger
SELECTION OF CITATIONS
SEARCH DETAIL